Transmission of tick-borne agents of disease by blood transfusion: A review of known and potential risks in the United States

Transfusion

Volumn 40, Issue 3, 2000, Pages 274-284

  McQuiston, J H ^b   Childs, James ^a   Chamberland, M E ^b   Tabor, E ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TETRACYCLINE DERIVATIVE;

BABESIOSIS; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE CARRIER; DISEASE TRANSMISSION; EHRLICHIOSIS; LYME DISEASE; REVIEW; RISK ASSESSMENT; ROCKY MOUNTAIN SPOTTED FEVER; SCREENING; TICK BITE; TICK BORNE DISEASE;

ANIMALS; BABESIOSIS; BLOOD TRANSFUSION; HUMANS; RISK FACTORS;

EID: 0034023012     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40030274.x     Document Type: Review

References (107)

1. Gerber MA, Shapiro ED, Krause PJ, et al. The risk of acquiring lyme disease or babesiosis from a blood transfusion. J Infect Dis 1994;170:231-4.
2. Marcus LC, Valigorsky JM, Fanning WL, et al. A case report of transfusion-induced babesiosis. JAMA 1982;248:465-7.
3. Herwaldt BL, Kjemtrup AM, Conrad PA, et al. Transfusion-transmitted babesiosis in Washington state: first reported case caused by a WA1-type parasite. J Infect Dis 1997;175:1259-62.
4. Wittner M, Rowin KS, Tanowitz HB, et al. Successful chemotherapy of transfusion babesiosis. Ann Intern Med 1982;96:601-4.
5. Mintz ED, Anderson IF, Cable RG, Hadler JL. Transfusion-transmitted babesiosis: a case report from a new endemic area. Transfusion 1991;31:365-8.
6. Dobroszycki J, Herwaldt BL, Boctor F, et al. A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor. JAMA 1999;281:927-30.
7. Chung APS, Leiby DA, Persing DH, et al. Seroprevalence of Babesia microti and Ehrlichia sp. in US blood donors (abstract). Transfusion 1998;38(Suppl):103S.
8. Wells GM, Woodward TE, Fiset P, Hornick RB. Rocky Mountain spotted fever caused by blood transfusion. JAMA 1978;239:2763-5.
9. Eastlund T, Persing D, Mathiesen D, et al. Human granulocytic ehrlichiosis after red cell transfusion. (abstract). Transfusion 1999;39(Suppl):117S.
10. Arguin PM, Singleton J, Rotz LD, et al. An investigation into the possibility of transmission of tick-borne pathogens via blood transfusion. Transfusion-Associated Tick-Borne Illness Task Force. Transfusion 1999;39:828-33.
11. Western KA, Benson GD, Gleason NN, et al. Babesiosis in a Massachusetts resident. N Engl J Med 1970;283:854-6.
12. Herwaldt BL, Persing DH, Precigout EA, et al. A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans. Ann Intern Med 1996;124:643-50.
13. Quick RE, Herwaldt BL, Thomford JW, et al. Babesiosis in Washington state: a new species of Babesia? Ann Intern Med 1993;119:284-90.
14. Persing DH, Herwaldt BL, Glaser C, et al. Infection with a babesia-like organism in northern California. N Engl J Med 1995;332:298-303.
15. Herwaldt BL, Springs FE, Roberts PP, et al. Babesiosis in Wisconsin: a potentially fatal disease. Am J Trop Med Hyg 1995;53:146-51.
16. Walker DH. Tick-transmitted infectious diseases in the United States. Annu Rev Public Health 1998;19:237-69.
17. Rosner F, Zarrabi MH, Benach JL, Habicht GS. Babesiosis in splenectomized adults. Review of 22 reported cases. Am J Med 1984;76:696-701.
18. Gelfand JA, Callahan MV. Babesiosis. Curr Clin Top Infect Dis 1998;18:201-16.
19. White DJ, Talarico J, Chang H, et al. Human babesiosis in New York state. Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998;158:2149-54.
20. Krause PJ, Spielman A, Telford SR, et al. Persistent parasitemia after acute babesiosis. N Engl J Med 1998;339:160-5.
21. Recommendations for the use of the new Lyme vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48RR:7:1-17, 21-5.
22. Steere AC, Malawista SE, Snydman DR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7-17.
23. Scrimenti RJ. Erythema chronicum migrans. Arch Dermatol 1970;102:104-5.
24. Summary of notifiable diseases, United States, 1996. MMWR Morb Mortal Wkly Rep 1997;45:1-87.
25. Sigal LH. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu Rev Immunol 1997;15:63-92.
26. Anderson BE, Dawson JE, Jones DC, Wilson KH. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol 1991;29:2838-42.
27. Chen S, Dumler IS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994;32:589-95.
28. Buller RS, Arens M, Hmiel SP, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med 1999;341:148-55.
29. McQuiston JH, Paddock CD, Holman RC, Childs JE. The human ehrlichioses in the United States. Emerg Infect Dis 1999;5:635-42.
30. Telford SR 3d, Dawson JE, Katavolos P, et al. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci U S A 1996;93:6209-14.
31. Anderson BE, Sims KG, Olson JG, et al. Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg 1993;49:239-44.
32. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994;120:736-43.
33. Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996;275:199-205.
34. Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York state. Ann Intern Med 1996;125:904-8.
35. Eng TR, Harkess JR, Fishbein DB, et al. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA 1990;264:2251-8.
36. Dumler JS, Bakken JS. Ehrlichial diseases of humans: emerging tick-borne infections. Clin Infect Dis 1995;20:1102-10.
37. Fritz CL, Glaser CA. Ehrlichiosis. Infect Dis Clin of North Am 1998;12:123-36.
38. Dalton MJ, Holman RC, Clarke MJ, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995;52:405-13.
39. Treadwell TA, Clarke MJ, Holman RC, et al. Summary of reported cases of Rocky Mountain spotted fever in the United States: 1993-1996. Am J Trop Med Hyg (in press).
40. Warner RD, Jemelka ED, Jessen AE. An outbreak of tick-bite-associated illness among military personnel subsequent to a field training exercise. J Am Vet Med Assoc 1996;209:78-81.
41. Rotz L, McKechnie D, Wolfe D, et al. An epidemiologic and entomologic investigation of a cluster of Rocky Mountain spotted fever cases in Delaware. Del Med J 1998;70:285-91.
42. Jones TF, Craig AS, Paddock CD, et al. Family cluster of Rocky Mountain spotted fever. Clin Infect Dis 1999;28:853-9.
43. Thorner AR, Walker DH, Petri W Jr. Rocky Mountain spotted fever. Clin Infect Dis 1998;27:1353-60.
44. Krause PJ, Telford SR, Spielman A, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA 1996;275:1657-60.
45. Spielman A. The emergence of Lyme disease and human babesiosis in a changing environment. Ann N Y Acad Sci 1994;740:146-56.
46. Mitchell PD, Reed KD, Hofkes JM. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol 1996;34:724-7.
47. Fritz CL, Kjemtrup AM, Conrad PA, et al. Seroepidemiology of emerging tickborne infectious diseases in a Northern California community. J Infect Dis 1997;175:1432-9.
48. Magnarelli LA, Dumler JS, Anderson JF, et al. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J Clin Microbiol 1995;33:3054-7.
49. Wong SJ, Brady GS, Dumler JS. Serological responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in patients from New York state. J Clin Microbiol 1997;35:2198-205.
50. Sexton DJ, Corey GR, Carpenter C, et al. Dual infection with Ehrlichia chaffeensis and a spotted fever group rickettsia: a case report. Emerg Infect Dis 1998;4:311-6.
51. Dennis DT, Nekomoto TS, Victor JC, et al. Reported distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the United States. J Med Entomol 1998;35:629-38.
52. Sonenshine DE. Zoogeography of the American dog tick, Dermacentor variabilis. In: Rodriguez JG, ed. Recent advances in acarology, vol. 2. New YorkAcademic Press, 1979;123-34.
53. Azad AF, Beard CB. Rickettsial pathogens and their arthropod vectors. Emerg Infect Dis 1998;4:179-86.
54. Boustani MR, Gelfand JA. Babesiosis. Clin Infect Dis 1996;22:611-5.
55. Strle F, Nadelman RB, Cimperman J, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 1999;130:32-6.
56. Piesman J, Mather TN, Sinsky RJ, Spielman A. Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol 1987;25:557-8.
57. Katavolos P, Armstrong PM, Dawson JE, Telford SR. Duration of tick attachment required for transmission of granulocytic ehrlichiosis. J Infect Dis 1998;177:1422-5.
58. Fish D, Levin M, desVignes F, Piesman J. Temporal and spatial dynamics of Ehrlichia phagocytophila transmission in northeastern USA (abstract). Presented at the EUWOG-ASR Joint Meeting, Marseilles, France, June 14-16 1999;61.
59. Krause PJ, Feder HM Jr. Lyme disease and babesiosis. Adv Pediatr Infect Dis 1994;9:183-209.
60. Dennis DT. Epidemiology, ecology and prevention of Lyme disease. In: Rahn DW, Evans J, eds. Lyme disease. Philadelphia: American College of Physicians, 1998:7-34.
61. Walker DH, Lane TW. Rocky Mountain spotted fever: clinical signs, symptoms, and pathophysiology. In: Walker DH, ed. Biology of rickettsial diseases, vol 1. Boca Raton: CRC Press, 1988;63-78.
62. Shih CM, Pollack RJ, Telford SR, Spielman A. Delayed dissemination of Lyme disease spirochetes from the site of deposition in the skin of mice. J Infect Dis 1992;166:827-31.
63. Iqbal Z, Chaichanasiriwithaya W, Rikihisa Y. Comparison of PCR with other tests for early diagnosis of canine ehrlichiosis. J Clin Microbiol 1994;32:1658-62.
64. Madigan JE, Richter PJ Jr, Kimsey RB, et al. Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J Infect Dis 1995;172:1141-4.
65. Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, et al. Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis 1998;27:1314-7.
66. Hackstadt T. The biology of rickettsia. Infect Agents Dis 1996;5:127-43.
67. Kaplowitz LG, Lange JV, Fischer JJ, Walker DH. Correlation of rickettsial titers, circulating endotoxin, and clinical features in Rocky Mountain spotted fever. Arch Intern Med 1983;143:1149-51.
68. Eberhard ML, Walker EM, Steurer FJ. Survival and infectivity of Babesia in blood maintained at 25C and 2-4C. J Parasitol 1995;81:790-2.
69. Johnson SE, Swaminathan B, Moore P, et al. Borrelia burgdorferi: survival in experimentally infected human blood processed for transfusion. J Infect Dis 1990;162:557-9.
70. Badon SJ, Fister RD, Cable RG. Survival of Borrelia burgdorferi in blood products. Transfusion 1989;29:581-3.
71. Nadelman RB, Sherer C, Mack L, et al. Survival of Borrelia burgdorferi in human blood stored under blood banking conditions. Transfusion 1990;30:298-301.
72. Foggie A. Studies on the infectious agent of tick-borne fever in sheep. J Pathol Bacteriol 1951;63:1-15.
73. Casleton BG, Salata K, Dasch GA, et al. Recovery and viability of Orientia tsutsugamushi from packed red cells and the danger of acquiring scrub typhus from blood transfusion. Transfusion 1998;38:680-9.
74. Horowitz HW, Kilchevsky E, Haber S, et al. Perinatal transmission of the agent of human granulocytic ehrlichiosis. N Engl J Med 1998;339:375-8.
75. Schlesinger PA, Duray PH, Burke BA, et al. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med 1985;103:67-8.
76. Cable RG, Krause P, Badon S, et al. Acute blood donor co-infection with Babesia microti (Bm) and Borrelia burgdorferi (Bb) (abstract). Transfusion 1993;33(Suppl):50S.
77. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts - blood transfusion. N Engl J Med 1999;340:438-47.
78. New uniform donor history questionnaire. Association Bulletin #98-3. AABB News Briefs 1998;20(June):12-5.
79. th ed. Bethesda: American Association of Blood Banks, 1996:73-102.
80. Popovsky MA, Lindberg LE, Syrek AL, Page PL. Prevalence of Babesia antibody in a selected blood donor population. Transfusion 1988;28:59-61.
81. Krause PJ, Telford SR 3d, Spielman A, et al. Comparison of PCR with blood smear and inoculation of small animals for diagnosis of Babesia microti parasitemia. J Clin Microbiol 1996;34:2791-4.
82. Hofmann H. Lyme borreliosis - problems of serological diagnosis. Infection 1996;24:470-2.
83. Wormser GP, Horowitz HW, Dumler JS, et al. False-positive Lyme disease serology in human granulocytic ehrlichiosis. Lancet 1996;347:981-2.
84. Filstein MR, Benach JL, White DJ, et al. Serosurvey for human babesiosis in New York. J Infect Dis 1980;141:518-21.
85. Hilton E, DeVoti J, Benach JL, et al. Seroprevalence and seroconversion for tickbome diseases in a high-risk population in the northeast United States. Am J Med 1999;106:404-9.
86. Krause PJ, Telford SR 3d, Pollack RJ, et al. Babesiosis: an underdiagnosed disease in children. Pediatrics 1992;89:1045-8.
87. Childs JE, Sumner JW, Nicholson WL, et al. Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol 1999;37:2997-3000.
88. Paddock CD, Greer PW, Ferebee TL, et al. Hidden mortality attributable to Rocky Mountain spotted fever: immuno-histochemical detection of fatal, serologically unconfirmed disease. J Infect Dis 1999;179:1469-76.
89. Anderson BE, Sumner JW, Dawson JE, et al. Detection of the etiologic agent of human ehrlichosis by polymerase chain reaction. J Clin Microbiol 1992;30:775-80.
90. Magnarelli LA, Stafford KC, Mather TN, et al. Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to Ehrlichiae and detection of DNA of the agent of human granulocytic ehrlichiosis by PCR. J Clin Microbiol 1995;33:2710-4.
91. Massung RF, Slater K, Owens JH, et al. Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol 1998;36: 1090-5.
92. Edelman DC, Dumler JS. Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol Diagn 1996;1:41-9.
93. Yu XJ, Crocquet-Valdes P, Walker DH. Cloning and sequencing of the gene for a 120-kDa immunodominant protein of Ehrlichia chaffeensis. Gene 1997;184:149-54.
94. Persing DH, Mathieson D, Marshall WF, et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol 1992;30:2097-103.
95. Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997;10:185-201.
96. Priem S, Rittig MG, Kamradt T, et al. An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis. J Clin Microbiol 1997;35:685-90.
97. Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 1998;36:2658-65.
98. Mouritsen CL, Wittwer CT, Litwin CM, et al. Polymerase chain reaction detection of Lyme disease: correlation with clinical manifestations and serologic response. Am J Clin Pathol 1996;105:647-54.
99. Bradley IF, Johnson RC, Goodman JL. The persistence of spirochetal nucleic acid in active Lyme arthritis. Ann Intern Med 1994;120:487-9.
100. Sexton DJ, Kanj SS, Wilson K, et al. The use of a polymerase chain reaction as a diagnostic test for Rocky Mountain spotted fever. Am J Trop Med Hyg 1994;50:59-63.
101. Carl M, Tibbs CW, Dobson ME, et al. Diagnosis of acute typhus infection using the polymerase chain reaction. J Infect Dis 1990;161:791-3.
102. Tzianabos T, Anderson BE, McDade JE. Detection of Rickettsia rickettsii DNA in clinical specimens by using polymerase chain reaction technology. J Clin Microbiol 1989;27:2866-8.
103. Grellier P, Santus R, Mouray E, et al. Photosensitized inactivation of Plasmodium falciparum- and Babesia divergans-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang 1997;72:211-20.
104. Corash L Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates. Vox Sang 1998;74:173-6.
105. Mettille FC, Salata KF, Belanger KJ, et al. Reducing the risk of transfusion transmission of rickettsial disease by WBC filtration, by using Orientia tsutsugamushi in a model system. Transfusion (in press).
106. America's Blood Centers Blood Products Advisory Committee recommends universal leukoreduction of blood components. ABC Newletter 1998;Sept 25:4-6.
107. Wilfert CM, MacCormack JN, Kleeman K, et al. The prevalence of antibodies to Rickettsia rickettsii in an area endemic for Rocky Mountain spotted fever. J Infect Dis 1985;151:823-31.